Auna Discloses That A Colombia Contract Resulted In Additional Temporary Cost Pressure Due To An Unexpected High Incidence Of Advanced-Stage Cancer Cases; Reaffirms FY26 Adjusted EBITDA Growth At Low End Of 10%-14% Range

Loading news article.

Auna Discloses That A Colombia Contract Resulted In Additional Temporary Cost Pressure Due To An Unexpected High Incidence Of Advanced-Stage Cancer Cases; Reaffirms FY26 Adjusted EBITDA Growth At Low End Of 10%-14% Range | WAPE

Auna Discloses That A Colombia Contract Resulted In Additional Temporary Cost Pressure Due To An Unexpected High Incidence Of Advanced-Stage Cancer Cases; Reaffirms FY26 Adjusted EBITDA Growth At Low End Of 10%-14% Range

Article summary

Related companies

Analyzed by WAPE AI.

Comments —